CZT

Spectrum Dynamics is proud to announce the Installation of the VERITON-CT SPECT/CT imaging system at European Leading Cancer Center, Gustave Roussy

Retrieved on: 
Thursday, March 21, 2024
Toxicity, CZT, Algorithm, Patient, Neoplasm, Hospital, 3D, Cancer, Gustave Roussy, Google Images, The, SPECT, SPECT/CT, Newsweek, Nuclear medicine, Health, Medical imaging

Gustave Roussy is considered as a leading cancer centre in Europe.

Key Points: 
  • Gustave Roussy is considered as a leading cancer centre in Europe.
  • The institute treats patients with all types of cancer at any age and is a leading institution in the treatment of rare and complex tumors.
  • It is unlike any other ring-shaped gantry, with a 360o CZT 12-detector design that automatically moves close to the patient's body.
  • "We are delighted to collaborate with Gustav Roussy with the install of the VERITON-CT 400 SPECT/CT scanner," says Johann Fernando, Executive Vice President, Spectrum Dynamics.

Alltech Joins Vital Group to Build an Industry Chain for High-End Medical Imaging

Retrieved on: 
Saturday, October 28, 2023
MRI, Innovation, Health, Alltech, International Medical Informatics Association, Research, CZT, Information technology, Artificial intelligence, CT, Magnetic resonance imaging, Hospital Insurance and Diagnostic Services Act, Patient, Medical device, Medical imaging

As one of the few global medical imaging companies capable of developing high-end superconducting products for magnetic resonance imaging (MRI), Alltech will leverage Vital Group's strengths in material science, information technology, and artificial intelligence, combined with its own expertise in medical imaging, to drive the development of state-of-the-art medical imaging products using cutting-edge technology such as 7.0T MRI and photon-counting CT.

Key Points: 
  • As one of the few global medical imaging companies capable of developing high-end superconducting products for magnetic resonance imaging (MRI), Alltech will leverage Vital Group's strengths in material science, information technology, and artificial intelligence, combined with its own expertise in medical imaging, to drive the development of state-of-the-art medical imaging products using cutting-edge technology such as 7.0T MRI and photon-counting CT.
  • With firm support from Vital Group, we are allowed to build up our portfolio of multi-modality imaging products.
  • Going forward, backed by Vital Group's mature business worldwide, Alltech will commit itself to building an industry chain for high-end medical imaging through deepened global strategic partnerships and consolidated resources at home and abroad, with the end goal of facilitating innovation and development of medical imaging technology.
  • We are confident that a more intelligent, precise, and personalized medical imaging industry will provide users and patients with better diagnostic services and treatment experiences, thereby improving the health of humanity.

Alltech Joins Vital Group to Build an Industry Chain for High-End Medical Imaging

Retrieved on: 
Saturday, October 28, 2023
MRI, Innovation, Health, Alltech, International Medical Commission on Bhopal, Research, Multimedia, CZT, Information technology, Artificial intelligence, CT, Magnetic resonance imaging, Hospital Insurance and Diagnostic Services Act, Patient, Medical device, Medical imaging

As one of the few global medical imaging companies capable of developing high-end superconducting products for magnetic resonance imaging (MRI), Alltech will leverage Vital Group's strengths in material science, information technology, and artificial intelligence, combined with its own expertise in medical imaging, to drive the development of state-of-the-art medical imaging products using cutting-edge technology such as 7.0T MRI and photon-counting CT.

Key Points: 
  • As one of the few global medical imaging companies capable of developing high-end superconducting products for magnetic resonance imaging (MRI), Alltech will leverage Vital Group's strengths in material science, information technology, and artificial intelligence, combined with its own expertise in medical imaging, to drive the development of state-of-the-art medical imaging products using cutting-edge technology such as 7.0T MRI and photon-counting CT.
  • With firm support from Vital Group, we are allowed to build up our portfolio of multi-modality imaging products.
  • Going forward, backed by Vital Group's mature business worldwide, Alltech will commit itself to building an industry chain for high-end medical imaging through deepened global strategic partnerships and consolidated resources at home and abroad, with the end goal of facilitating innovation and development of medical imaging technology.
  • We are confident that a more intelligent, precise, and personalized medical imaging industry will provide users and patients with better diagnostic services and treatment experiences, thereby improving the health of humanity.

Global Photon Counter Market to Surpass USD 3.36 Billion By 2031| Growth Market Reports

Retrieved on: 
Friday, June 9, 2023
Photon, DNA, Medical applications of radio frequency, Radiation, Completeness, SHM, Cadmium telluride, IoT Forensics, Key, Pulse, Projection, Investment, CZT, Internet of things, Diagnosis, Cadmium zinc telluride, Retail, Online shopping, Medical imaging, Microscope, Silicon, Growth, Forecast

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5240

Key Points: 
  • For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5240
    On the basis of region, the global photon counter market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • The demand for photon counters is growing in the medical industries, which is a major driver of the photon counter market.
  • Applications of photon counters in digital holography and the emergence of x-ray photon counting are factors likely to create growth prospects for market players.
  • On the basis of types, the photon counter market is divided into basic types, background compensation types, and radiation source compensation types.

Global Photon Counter Market to Surpass USD 3.36 Billion By 2031| Growth Market Reports

Retrieved on: 
Friday, June 9, 2023
Photon, DNA, Medical applications of radio frequency, Radiation, Completeness, SHM, Cadmium telluride, IoT Forensics, Key, Pulse, Projection, Investment, CZT, Internet of things, Diagnosis, Cadmium zinc telluride, Retail, Online shopping, Medical imaging, Microscope, Silicon, Growth, Forecast

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5240

Key Points: 
  • For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5240
    On the basis of region, the global photon counter market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • The demand for photon counters is growing in the medical industries, which is a major driver of the photon counter market.
  • Applications of photon counters in digital holography and the emergence of x-ray photon counting are factors likely to create growth prospects for market players.
  • On the basis of types, the photon counter market is divided into basic types, background compensation types, and radiation source compensation types.

Nuclear Medicine Global Market Report 2022: Increasing Prevalence of Cardiovascular Disease Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 27, 2022
General Health, Pharmaceutical, Health, Benchmark, Cancer, Agriculture, Cardiovascular disease, CVD, Stroke, Coronavirus, Public health, Cardiology, Weakness, Fatality, CZT, Disease, Growth, Nuclear medicine, World Health Organization, Neurology, GE Healthcare, Heart, Hospital, Degenerative disease, Lymphoma, Create, Prevalence, WHO, Cell, Medical imaging, Oil, Marketing

The "Nuclear Medicine Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nuclear Medicine Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.
  • The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward.
  • As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market.
  • Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine market.

25GS-PON continues to gain global traction with service providers and vendor community

Retrieved on: 
Monday, October 17, 2022
KPN, Deutsche Telekom, DZS, Cox Communications, RAI Amsterdam, Interphone, MSA, AT, PON, WNC, AIS, Ciena, JPC, Gruppo TIM, Broadband Forum, CableLabs, Network, AOI, EPB, AT&T, EXFO, YANG, Telekom, Bell Canada, Accton Technology Corporation, MaxLinear, RAI Amsterdam Convention Centre, Technology, CZT, Ecosystem, NBN Co, Interoperability, BBF, Forum, Pegatron, Business, Electronics, CommScope, Chunghwa Telecom, MT2, Pharmaceutical industry, Mobile phone, Chorus, BFW, Semtech, Hotwire, Openreach, Telus

This is a key development as 25GS-PON technology continues to mature, verifying that equipment, products, and systems from different companies function and seamlessly communicate as required by the 25GS-PON specification.

Key Points: 
  • This is a key development as 25GS-PON technology continues to mature, verifying that equipment, products, and systems from different companies function and seamlessly communicate as required by the 25GS-PON specification.
  • The Broadband Forum has agreed to start work on an interoperability test specification and a YANG data model for 25GS-PON.
  • BBF isthe communications industrys leading open standards development organization focused on accelerating broadband innovation, standards, and ecosystem development.
  • 25GS-PON meets the needs of the mobile 5G era and large-scale enterprises, providing communications service providers with the most cost-effective and timely evolution path for PON fiber technology.

Spectrum Dynamics Medical and Kromek Group plc announce the introduction of the world's first digital SPECT/CT scanner using Kromek digital detectors for higher sensitivity and throughput.

Retrieved on: 
Monday, October 17, 2022
Quality of life, Nuclear medicine, Efficiency, KMK, Bomb, SPECT/CT, Algorithm, OEM, SPECT, Hospital, London Stock Exchange, Alzheimer's disease, Multimedia, AIM, Technology, Cancer, CT, CZT, Group, CEO, Face, London, Solution, View, Medical imaging, Television, Spectrum, CBRN

SARASOTA, Fla, Oct. 16, 2022 /PRNewswire/ -- Spectrum Dynamics Medical, a global leader in digital Nuclear Medicine SPECT and SPECT/CT scanners, and Kromek Group plc, a leading developer of high-performance detectors based on cadmium zinc telluride (CZT), today announced the integration of Kromek CZT detectors in Spectrum digital SPECT/CT products, the VERITON-CT 400 series.

Key Points: 
  • The 400 Series digital detector technology sets new standards with a 2-4 times improvement in energy range, system sensitivity, and energy resolution.
  • "Clinical users across the world provide us with feedback on the Nuclear Medicine challenges they face," said Spectrum Dynamics' CEO, Gilad Yoeli.
  • This enables enhanced image quality and breakthrough clinical capabilities in digital SPECT/CT," said Arnab Basu, CEO of Kromek Group plc.
  • In 2018, Spectrum Dynamics launched its multipurpose VERITON and the VERITON-CT SPECT/CT, the first ring-based 360 CZT digital SPECT/CT scanner.

Outlook on the Coronary Heart Disease Diagnostic Imaging Devices Global Market to 2030 - Featuring GE Healthcare, Fujifilm, Siemens Healthineer and Toshiba Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 19, 2022
Health, Medical Devices, Cardiology, Chapter Three, CZT, Acquisition, Patient, CT scan, Hospital, CTCA, National Association Medical Staff Services, CVD, CAGR, Asia-Pacific, Moyamoya disease, Diabetes, Technology, Adoption, Computed tomography angiography, Hypertension, Myocardial perfusion imaging, Death, CHD, Medical imaging, COVID-19, Risk, Growth, Nuclear medicine, Diagnosis, PET, SPECT, Coronary artery disease, Pharmaceutical industry

For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries.

Key Points: 
  • For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries.
  • The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic.
  • Thus, the pandemic significantly impacted the market in 2020, which is likely to stabilize and grow exponentially by 2022.
  • Coronary Heart Disease Diagnostic Imaging Devices Market Variables, Trends & Scope

Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care

Retrieved on: 
Thursday, June 9, 2022
FDA, Other Health, Technology, Radiology, Pharmaceutical, Oncology, Hospitals, Men, Other Technology, Biotechnology, Science, Alternative Medicine, Other Science, Consumer, Research, Health, Molecule, Radioligand, SNMMI, Time, University of Michigan, CZT, College of Arts and Sciences, Associate, SNR, Organic, Sale, CT, Technology, NYSE, COVID-19, Research, Molecular imaging, Radiopharmaceutical, Nuclear medicine, Cyclotron, News, CEO, CE, Ecosystem, Solution, Artificial intelligence, Federal Food, Drug, and Cosmetic Act, Health, Thomas Edison, Diagnosis, PET/CT, Industry, Radiation, Collection, WEHR, Patient, GE Healthcare, PET/MR, World Health Organization, Noise, Prostate cancer, PET-CT, Radionuclide, University, Physician, Efficiency, Discovery, NEMA, SPECT, PET, Prostate Cancer Foundation, PSMA, Man, LinkedIn, Disease, FDA, FOV, Biology, Risk, Society of Nuclear Medicine and Molecular Imaging, Twitter, CT scan, Medical imaging, Pharmaceutical industry, Medical device, Palladium, Cancer, Radiology, Gallium, Facebook

GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer the most prevalent cancer in men and the third most prevalent cancer overalli.

Key Points: 
  • GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer the most prevalent cancer in men and the third most prevalent cancer overalli.
  • Healthcare is timely and personal and its delivery should be too, explains Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE Healthcare.
  • To prepare for the creation of dedicated theranostics centers, SNMMI and related international molecular imaging societies recently published a new guide for healthcare systems globallyiii.
  • As the industry prepares to usher in this new era of precision health and personalized medicine, GE Healthcare is proud to offer innovative molecular imaging solutions to healthcare systems around the world.